clarithromycin has been researched along with Chlamydia pneumoniae Infections in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammerschlag, MR; Kohlhoff, SA; Parker, C; Roblin, PM | 1 |
| Beckett, EL; Essilfie, AT; Foster, PS; Gibson, PG; Hansbro, PM; Horvat, JC; Kim, RY; Mayall, JR; Pinkerton, JW; Simpson, JL; Starkey, MR | 1 |
| Brusselle, GG | 1 |
| Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Miyashita, N; Morinaga, Y; Mukae, H; Seki, M; Yamada, Y; Yamamoto, Y; Yanagihara, K | 1 |
| Hu, L; Hu, X; Lu, Z; Wang, D; Zhang, Y | 1 |
| Als-Nielsen, B; Damgaard, M; Gluud, C; Hansen, JF; Hansen, S; Helø, OH; Hildebrandt, P; Hilden, J; Jensen, GB; Jespersen, CM; Kastrup, J; Kjøller, E; Kolmos, HJ; Lind, I; Nielsen, H; Petersen, L | 2 |
| Abildstrøm, SZ; Andersen, SS; Folke, F; Fosbøl, EL; Gislason, GH; Hansen, ML; Køber, L; Madsen, M; Norgaard, ML; Raunsø, J; Torp-Pedersen, C | 1 |
| Goto, H | 1 |
| Ferreri, AJM | 1 |
| Fitting, JW; Greub, G; Jaton, K; Senn, L | 1 |
| Baglioni, S; Eslami, A; Todisco, C; Todisco, T | 1 |
| Salo, K; Surcel, HM; Tuuminen, T | 1 |
| Fukano, H; Matsushima, T; Miyashita, N; Niki, Y; Yoshida, K | 1 |
| Muhlestein, JB | 1 |
| Berg, HF; Kluytmans, JA; Maraha, B; Peeters, MF; Quarles-van Ufford, M; Scheffer, GJ; Vandenbroucke-Grauls, CM | 1 |
| Ichihara, E; Kanehiro, A; Kiura, K; Kubo, T; Miyahara, N; Tabata, M; Takigawa, N; Tanimoto, M; Tanimoto, Y | 1 |
| Hammerschlag, MR | 1 |
| Abbate, R; Acciai, S; Mazzoli, S; Pazzagli, L; Rabatti, L; Taddei, V; Vergassola, R | 1 |
1 review(s) available for clarithromycin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
Antibiotic treatment of atherosclerosis.
Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome | 2003 |
4 trial(s) available for clarithromycin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Bacterial; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Disease; Female; Humans; Immunoglobulin A; Immunoglobulin G; Male; Middle Aged; Placebos; Prognosis; Risk Factors | 2010 |
An open, comparative pilot study of thiamphenicol glycinate hydrochloride vs clarithromycin in the treatment of acute lower respiratory tract infections due to Chlamydia pneumoniae.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Drug Administration Schedule; Female; Humans; Immunoglobulins; Male; Middle Aged; Pilot Projects; Pneumonia, Bacterial; Radiography; Thiamphenicol; Treatment Outcome | 2002 |
Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.
Topics: Aged; Angina, Unstable; Anti-Bacterial Agents; Atherosclerosis; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Bypass; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Surgical Wound Infection; Treatment Outcome | 2005 |
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina Pectoris; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Humans; Middle Aged; Myocardial Infarction; Treatment Outcome | 2006 |
14 other study(ies) available for clarithromycin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila Infections; Chlamydophila pneumoniae; Female; Humans; Infant; Macrolides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Triazoles | 2010 |
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Asthma; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Dexamethasone; Disease Models, Animal; Female; Glucocorticoids; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C | 2015 |
Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Asthma; Azithromycin; Bronchiolitis Obliterans; Chlamydophila Infections; Clarithromycin; Female; Haemophilus Infections; Humans; Lung Transplantation; Male | 2015 |
Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Blotting, Western; Cells, Cultured; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Ketolides; Mice; Mucin 5AC; NF-kappa B; NF-kappa B p50 Subunit; Respiratory Mucosa; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factor RelA | 2009 |
Macrolide antibiotics aggravate experimental autoimmune encephalomyelitis and inhibit inducible nitric oxide synthase.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Azithromycin; Blotting, Western; Cells, Cultured; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation, Enzymologic; Leukocytes, Mononuclear; Macrolides; Nitric Oxide; Nitric Oxide Synthase Type II; Oligopeptides; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2009 |
Clarithromycin use and risk of death in patients with ischemic heart disease.
Topics: Adult; Aged; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors | 2010 |
Multicenter surveillance of adult atypical pneumonia in Japan: its clinical features, and efficacy and safety of clarithromycin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Female; Humans; Japan; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Prospective Studies; Statistics, Nonparametric; Treatment Outcome | 2011 |
Activity of clarithromycin in mucosa-associated lymphoid tissue-type lymphomas: antiproliferative drug or simple antibiotic?
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Chlamydophila; Chlamydophila Infections; Clarithromycin; Helicobacter; Helicobacter Infections; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Treatment Outcome | 2011 |
Does respiratory infection due to Chlamydia pneumoniae still exist?
Topics: Adolescent; Bacterial Load; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Cough; Diagnosis, Differential; DNA, Bacterial; Female; Humans; Male; Middle Aged; Nasopharynx; Pneumonia, Bacterial; Polymerase Chain Reaction; Respiratory Tract Infections; Sputum | 2011 |
A casuistic immunologic response in primary and repeated Chlamydophila pneumoniae infections in an immunocompetent individual.
Topics: Adult; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Female; Humans; Immunocompetence; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Interferon-gamma; Interleukin-10; Recurrence | 2002 |
Chlamydia pneumoniae infection in adult patients with persistent cough.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Cough; Female; Humans; Male; Middle Aged | 2003 |
[Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].
Topics: Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Treatment Outcome | 2007 |
Treatment of Chlamydia pneumoniae.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibodies, Bacterial; Azithromycin; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Pneumonia, Bacterial | 2000 |
[Chlamydia pneumoniae and myocardial infarction (CLINF). Preliminary randomized controlled study with clarithromycin. CLAINF protocol].
Topics: Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic | 2000 |